Randomized Phase II Study of Ixabepilone Plus Trastuzumab vs. Docetaxel Plus Trastuzumab in Female Subjects With Her2+ Locally Advanced and/or Metastatic Breast Cancer. [Estudio fase II de Ixabepilona y Trastuzumab versus Docetaxel y Trastuzumab en mujeres con cáncer de mama localmente avanzado y/o mestatásico con sobresexpresión de Her2].
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2016
At a glance
- Drugs Docetaxel; Ixabepilone; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Mar 2012 The trial status is recruiting in (Spain and France) and prematurely ended in (Italy) as reported by European Clinical Trials Database.
- 02 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.